Allarity Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Allarity Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q1 2024.
  • Allarity Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$4K.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $83K.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.52M, a 1244% decline from 2021.
  • Allarity Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $133K, a 32.8% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2022 -$1.52M -$303K -$338K -966% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$1.18M $5K -$30K -85.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.15M $4K -$26K -86.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.13M -$1.23M -$1.26M -3818% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $133K $35K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $35K -$15K -30% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $30K Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-07
Q1 2021 $33K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-27
Q3 2020 $50K Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.